GENECORE Trademark

Trademark Overview

On Monday, September 1, 2025, a trademark application was filed for GENECORE with the United States Patent and Trademark Office. The USPTO has given the GENECORE trademark a serial number of 99368313. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, February 2, 2026. The GENECORE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific investigations for medical purposes; Genetic testing for scientific research purposes; Medical and scientific research in the field of biotechnology
genecore

General Information

Serial Number99368313
Word MarkGENECORE
Filing DateMonday, September 1, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, February 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkGENE CORE
Goods and ServicesScientific investigations for medical purposes; Genetic testing for scientific research purposes; Medical and scientific research in the field of biotechnology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, September 1, 2025
Primary Code042
First Use Anywhere DateTuesday, August 8, 2023
First Use In Commerce DateWednesday, November 30, 2022

Trademark Owner History

Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressChicago, IL 60607

Trademark Events

Event DateEvent Description
Monday, September 1, 2025NEW APPLICATION ENTERED
Monday, September 1, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 21, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 22, 2026ASSIGNED TO EXAMINER
Wednesday, January 28, 2026NON-FINAL ACTION WRITTEN
Wednesday, January 28, 2026NON-FINAL ACTION E-MAILED
Wednesday, January 28, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 28, 2026NON-FINAL ACTION WRITTEN
Wednesday, January 28, 2026NON-FINAL ACTION E-MAILED
Wednesday, January 28, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 2, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 2, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 2, 2026TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

genecore scientific purposes medical research field biotechnology genetic investigations testing